Izotropic Corporation (OTCMKTS:IZOZF – Get Free Report) saw a significant drop in short interest during the month of October. As of October 30th, there was short interest totaling 9,609 shares, a drop of 89.6% from the October 15th total of 92,598 shares. Based on an average daily trading volume, of 67,127 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are sold short.
Izotropic Trading Down 4.0%
OTCMKTS:IZOZF traded down $0.00 on Friday, hitting $0.09. The stock had a trading volume of 10,313 shares, compared to its average volume of 24,504. Izotropic has a 52-week low of $0.07 and a 52-week high of $0.28. The business’s 50-day simple moving average is $0.12 and its two-hundred day simple moving average is $0.17.
Izotropic (OTCMKTS:IZOZF – Get Free Report) last posted its quarterly earnings results on Monday, September 28th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02). Analysts expect that Izotropic will post 0.03 EPS for the current year.
About Izotropic
Izotropic Corporation is a medical technology company focused on developing dedicated breast computed tomography (CT) imaging systems. Its principal product is the IzoView breast CT system, designed to produce three-dimensional images of the breast without the compression typically used in conventional mammography. The company’s technology is intended to support breast-cancer screening and diagnostic imaging by providing detailed volumetric images that may help clinicians evaluate breast tissue and abnormalities.
Further Reading
- Five stocks we like better than Izotropic
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
